Share this article
MONTRÉAL, Jan. 21, 2021 /PRNewswire/ -
Eli, a company enabling women to own their fertility and health decisions with a novel hormone tracking technology, today announced its $1.5 million USD seed round co-led by Vectr Ventures and 2048 Ventures. The round closed in December 2020 with the participation of Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and serial entrepreneur Steven Arless, who also joined the board.The round brings the company's total funding since its creation in mid-2019 to $2.1 million USD. This amount includes a previous investment from Techstars and Real Ventures via Techstars Montréal AI.
"Hormones are core to women's fertility and general health, yet they remain a black box. We are unlocking that box and empowering women to have access to their own hormone data daily,"